Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment.

Vikelis M, Argyriou AA, Dermitzakis EV, Spingos KC, Makris N, Kararizou E

Open source

DOI: 10.1186/s10194-018-0918-3
Published: 2018 Sep 17
Container: The journal of headache and pain
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s10194-018-0918-3,
  title = {Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment.},
  author = {Vikelis M and Argyriou AA and Dermitzakis EV and Spingos KC and Makris N and Kararizou E},
  year = {2018},
  journal = {The journal of headache and pain},
  doi = {10.1186/s10194-018-0918-3},
  url = {https://doi.org/10.1186/s10194-018-0918-3}
}

RIS

TY  - JOUR
TI  - Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment.
AU  - Vikelis M
AU  - Argyriou AA
AU  - Dermitzakis EV
AU  - Spingos KC
AU  - Makris N
AU  - Kararizou E
PY  - 2018
JO  - The journal of headache and pain
DO  - 10.1186/s10194-018-0918-3
UR  - https://doi.org/10.1186/s10194-018-0918-3
ER  -

APA

M, V., AA, A., EV, D., KC, S., N, M., & E, K. (2018). Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment.. The journal of headache and pain. https://doi.org/10.1186/s10194-018-0918-3

Source records

pubmed · retrieved 2026-09-26T06:35:04.991Z
europe-pmc · retrieved 2026-09-26T06:35:04.999Z
doaj · retrieved 2026-09-26T06:35:04.992Z